01.13.21

EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 Vaccine

Source: FirstWord

11.30.20

UK Government Asks Regulator to Clear “Temporary Supply” of AstraZeneca’s COVID-19 Vaccine

Source: FirstWord

11.23.20

AstraZeneca Says COVID-19 Vaccine Candidate Shows 70% Efficacy

Source: FirstWord

10.27.20

AstraZeneca’s COVID-19 Vaccine Produces Robust Immune Response in Elderly

Source: FirstWord

10.26.20

AstraZeneca, J&J Say Their COVID-19 Vaccine Trials Back on Track in US

Source: FirstWord

10.22.20

Suspected Control Group Participant in AstraZeneca COVID-19 Vaccine Study Dies; Trial Continues

Source: FirstWord

10.21.20

Sources Say US Study of AstraZeneca’s COVID-19 Vaccine May Restart This Week

Source: FirstWord

10.02.20

EMA Starts Rolling Review of AstraZeneca’s COVID-19 Vaccine Candidate AZD1222

Source: FirstWord

09.17.20

Oxford Says AstraZeneca Trial Illnesses May Not Be Linked to COVID-19 Vaccine

Source: FirstWord

09.16.20

FDA Probes Whether to Allow AstraZeneca to Resume COVID-19 Vaccine Trial in US

Source: FirstWord

View more stories